BALCX | CBLRX | BALCX / CBLRX | |
Total Expense Ratio | 1.31 | 1.18 | 111% |
Annual Report Gross Expense Ratio | 1.31 | 1.18 | 111% |
Fund Existence | 24 years | 15 years | - |
Gain YTD | 4.121 | 2.534 | 163% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 244B | 9.61B | 2,540% |
Annual Yield % from dividends | 1.24 | 1.53 | 81% |
Returns for 1 year | 4.49 | 0.70 | 643% |
Returns for 3 years | 30.13 | 28.95 | 104% |
Returns for 5 years | 34.15 | 26.80 | 127% |
Returns for 10 years | 51.38 | 50.56 | 102% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VIVIX | 67.63 | -0.55 | -0.81% |
Vanguard Value Index I | |||
JOEIX | 13.08 | -0.11 | -0.83% |
JOHCM Emerging Markets Opps Advisor | |||
LAMHX | 23.81 | -0.26 | -1.08% |
Lord Abbett Dividend Growth R6 | |||
VIDGX | 11.63 | -0.17 | -1.44% |
Vanguard International Dividend Gr Inv | |||
BRWAX | 25.10 | -0.37 | -1.45% |
MFS Blended Research Growth Eq A |